Blog

New Leadership and Promotions Strengthen The Daniel Group’s CX Expertise and Growth Strategy

CHARLOTTE, NC / ACCESS Newswire / August 18, 2025 / The Daniel Group announces the addition of Bryan Gregory as Vice President of the CX Solutions. Bryan brings a unique blend of leadership operational excellence, and creative communication to the organization, further strengthening its mission to help their clients measure, manage, and improve their customer experiences (CX).

Bryan’s career spans more than two decades of leadership in broadcast journalism, marketing, training, and customer engagement. Beginning his professional journey as a three-time Northeast Emmy Award-winning television director and producer, Bryan spent over a decade at Advance Auto Parts, serving as both Director of Marketing and Senior Director of Training & Customer Engagement. While leading a team of 46 serving 72,000 employees, he earned seven national training awards, including Learning Elite and multiple ADDY Awards for video-based learning initiatives.

A certified ASE Mechanic, Gregory co-hosted the nationally televised “Tech Garage” on Motor Trend TV, reaching 88 million homes. Most recently, he served as a Senior Leader in Customer, Employee, and Retail Experience at Carter Machinery, one of North America’s top Caterpillar dealers. His distinctive approach to leadership-what he calls “edu-tainment”-combines strategic vision with engaging, memorable communication that connects with both customers and employees.

“I am thrilled to join this tremendously successful, customer-centric organization that shares my passion to help, guide, and accelerate world-class CX/EX every single day. The Daniel Group has perfected the customer experience of gathering valuable feedback, insight anytime, anywhere, and anyway their customers want to share…so helping our customers get better at getting better is very exciting!”

The Daniel Group is also proud to recognize the following internal promotions:

Kim Battles is now the Director of CX Deliverables. Kim joined nearly three years ago and has played a pivotal role in advancing client success initiatives and leading the Business Support Analysts and Client Success Managers teams.

Lisa Lyle is now a Senior Client Success Manager. Lisa has been with The Daniel Group for 18 years and is known for her deep client relationships and proven ability to deliver solutions. Her expanded role will further enhance the company’s ability to drive measurable outcomes for clients.

“These leadership moves position us to serve our clients better while building a stronger foundation for future growth,” said Lynn Daniel, Founder and CEO. “Bryan’s expertise and proven results in driving customer and employee engagement, combined with Kim and Lisa’s well-earned promotions, strengthen our ability to deliver exceptional experiences across the board.”

About The Daniel Group
The Daniel Group helps B2B companies create exceptional customer experiences through a comprehensive suite of CX services. From email surveys and digital feedback tools to reporting, insights, and program support, The Daniel Group equips organizations with the tools they need to measure, manage, and improve every stage of the customer journey. Headquartered in Charlotte, N.C., the firm serves a wide range of industrial, manufacturing, and service-based clients across North America.

For more information about The Daniel Group and its CX solutions, visit thedanielgroup.com.

SOURCE: The Daniel Group

View the original press release on ACCESS Newswire

MONTRÉAL, QC / ACCESS Newswire / August 18, 2025 / Vision Marine Technologies Inc. (the “Company”, “Vision Marine”, “we”, “us”, “our”) (Nasdaq:VMAR), a leader in high-voltage electric marine propulsion systems with a multi-brand boat retail and service platform, today announced the closing of its previously announced public offering of 3,500,000 shares of its common stock (or pre-funded warrants (“Pre-Funded Warrants”) in lieu thereof) at a public offering price of $2.00 per share (inclusive of the Pre-Funded Warrant exercise price), for gross proceeds of $7,000,000, before deducting underwriting discounts and offering expenses. In addition, Vision Marine has granted the underwriters a 45-day option to purchase up to an additional 525,000 shares of common stock and/or Pre-Funded Warrants to cover over-allotments at the public offering price, less the underwriting discount.

The Company intends to use the proceeds for general corporate purposes, working capital, and potential acquisitions or strategic investments in complementary businesses or technologies.

ThinkEquity acted as sole book-running manager for the offering.

A registration statement on Form F-1 (File No. 333-289547) relating to the shares was filed with the Securities and Exchange Commission (“SEC”) and became effective on August 15, 2025. This offering is being made only by means of a prospectus. Copies of the final prospectus may be obtained from ThinkEquity, 17 State Street, 41^st Floor, New York, New York 10004.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Vision Marine Technologies, Inc.

Vision Marine Technologies Inc. (NASDAQ:VMAR) is a pioneer in high-voltage performance electric marine propulsion with a multi-brand boat retail and service platform. The Company designs, manufactures, and sells its flagship E-Motion™ 180E high-voltage electric outboard system-an industrialized, high-performance solution validated through multiple OEM integrations-while also providing consumers with access to a full range of boats across both electric and internal combustion engine (ICE) segments through its Nautical Ventures division. With nine retail locations in Florida and established sales, service, and marina operations, Vision Marine delivers market-ready solutions to meet the current and evolving needs of recreational boaters and commercial operators.

Forward Looking Statements

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements include predictions, expectations, estimates, and other information that might be considered future events or trends, not relating to historical matters. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. Vision Marine’s Annual Report on Form 20-F for the year ended August 31, 2024, and its periodic filings with the SEC provide a detailed discussion of these risks and uncertainties. There can be no assurance that Vision Marine will be able to complete the offering on the anticipated terms, or at all. Vision Marine does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, as required by law.

Investor and Company Contact:

Bruce Nurse
Investor Relations
(303) 919‑2913
bn@v‑mti.com

SOURCE: Vision Marine Technologies Inc.

View the original press release on ACCESS Newswire

By Editorial Evrima Chicago

JESSUP, MD / ACCESS Newswire / August 18, 2025 / When Dr. Rachel Bonaparte first envisioned The Blacklining, she wasn’t thinking about just launching a business directory. She was designing a blueprint for a cultural intervention; a living digital space where visibility, capital, knowledge, and community all converge for one purpose: economic sovereignty for Black entrepreneurs.

Launched the week of Juneteenth, the Blacklining is more than timely. It’s urgent. In a nation where Black-owned businesses face systemic disadvantages across capital access, mentorship, visibility, and educational infrastructure, this platform aims to do what legacy institutions have failed to do: integrate support, education, and community engagement into one cohesive system.

The Problem: Fragmentation, Disparity, and Disconnection

The data is as damning as it is consistent. According to the Federal Reserve, Black-owned businesses are twice as likely to be denied credit as their white counterparts. Less than 1% of venture capital goes to Black founders. And despite rising rates of entrepreneurship, financial literacy remains one of the most persistent obstacles to scaling successfully.

Existing platforms often address fragments of the problem; directories, mentorship hubs, or e-learning modules. But as Bonaparte’s own research and lived experience made clear: Black entrepreneurs don’t need piecemeal solutions; they need ecosystems.

The Solution: A Full-Spectrum Platform for Empowerment

The Blacklining was created to bridge these gaps. Its features include:

• A dynamic directory of Black-owned businesses across sectors

• Financial literacy modules including webinars, articles, and community-led workshops

• Event listings that allow businesses to post upcoming launches, pop-ups, and virtual panels

• Business Ideas Pages; a social-forum-style feed where members can ideate, ask, collaborate, and engage.

• Interactive learning spaces to build real-world business skills from trusted experts

What makes this truly revolutionary is the synergy between these tools. “We’ve designed this so that your directory listing isn’t the end goal; it’s your starting point,” Bonaparte explains. “This is where entrepreneurs grow roots and start building sustainable visibility and community capital.”

Juneteenth as Launch Symbolism

Choosing the week of Juneteenth for the official launch wasn’t just symbolic; it’s intentional.

“Juneteenth commemorates delayed freedom. In many ways, Black entrepreneurs are still waiting for the freedom to scale, the freedom to access, the freedom to lead markets without systemic friction,” Bonaparte says. “This platform launches to accelerate that freedom; not just remember it.”

Financial Literacy as Foundation

In one of the most poignant insights from their market analysis, The Blacklining team cites a disturbing stat: Black Americans score an average of 38% on financial literacy assessments, compared to 55% among white Americans.

But instead of approaching this with shame-based messaging, the platform responds with radical empowerment: free financial education workshops, real-time strategy webinars, and beginner-friendly digital toolkits.

And unlike most content marketplaces, these aren’t behind a paywall. The freemium model ensures access; the premium model enhances it.

Strategic Revenue, Ethical Scale

From a business model standpoint, The Blacklining is impressively thoughtful. Its revenue streams include:

• Tiered subscription services (from Supporter to Thrive)

• Advertising packages for Black-owned and ally brands

• Commission-based affiliate partnerships with financial tools and services

• Ticketed workshops and coaching office hours

And yet, its monetization strategy never eclipses its equity-first mission. “Our pricing model is designed to serve sustainability, not exclusion,” Bonaparte emphasizes.

Corporate Partners and Institutional Backing

The platform’s traction is already evident. Warner Bros., Feeding America, and World Central Kitchen have come on board with sponsorship badges; and institutional interest is growing fast. Banks, colleges, and economic development agencies have begun exploratory partnerships to incorporate The Blacklining into outreach and entrepreneurship support programs.

Community First; Always

What may be most groundbreaking is what’s not transactional.

The Blacklining’s Business Exchange Pages allow for real-time networking, feedback loops, accountability threads, and even political advocacy. It’s LinkedIn meets Reddit, but with a cultural heartbeat.

“The way Black entrepreneurs build isn’t isolated; it’s communal. Our platform is the first to mirror that truth,” Bonaparte says.

---

Looking Ahead: Mentorship, Expansion, and Localized Ecosystems

With the national rollout already in motion, the next phase of The Blacklining includes:

• Localized mentorship pods connecting new entrepreneurs with seasoned professionals

• Multi-language platform capabilities to support Afro-Caribbean, Francophone, and African-based entrepreneurs

• A dedicated mobile app with integrated chat and event push notifications

• State-by-state rollouts designed with regional economic data in mind

It’s a plan that’s both scalable and rooted; something Bonaparte calls “strategic elasticity.”

Conclusion: This Is Not a Moment; It’s a Movement

In a world full of apps, databases, and course bundles, The Blacklining does something more radical: it invites Black entrepreneurs to own the means of their visibility, their literacy, and their legacy.

The Blacklining isn’t asking for permission to lead; it’s just turning the lights on for everyone else to follow.

---

Disclaimer

• ^{This article has been authored, prepared, and distributed by Evrima Chicago, LLC in its capacity as the official editorial and media representative for Dr. Rachel Bonaparte and The Blacklining.}

• ^{All views, statements, and claims expressed in this article originate from Dr. Rachel Bonaparte and/or The Blacklining project team.}

• ^{Evrima Chicago does not independently verify, endorse, or guarantee the accuracy or completeness of any statements, statistics, or representations herein.}

• ^{The article is provided strictly for informational, cultural, and journalistic purposes. It does not constitute legal, financial, or business advice.}

• ^{Readers, researchers, and third parties interested in verifying any claims should contact Dr. Rachel Bonaparte or The Blacklining organization directly, or refer to primary source materials and cited references.}

• ^{Evrima Chicago reserves the right to edit content for clarity, style, and publication standards, without altering the intended meaning or message provided by the subject.}

• ^{All media inquiries, rights requests, and syndication matters for The Blacklining should be directed to the PR & Media Contact below.}

---

PR & Media Contact

Dan Wasserman
Team Editorial
PR@EvrimaChicago.com

SOURCE: Evrima Chicago LLC.

View the original press release on ACCESS Newswire

BOCA RATON, FL / ACCESS Newswire / August 18, 2025 / Newsmax Inc. (NYSE:NMAX) (“Newsmax” or the “Company”) today announced that the Company has reached a settlement agreement with Dominion Voting Systems, concluding a defamation lawsuit that Dominion filed in Delaware Superior Court in 2021.

In a filing submitted Monday with the U.S. Securities and Exchange Commission, Newsmax disclosed that the parties have mutually agreed to resolve the litigation for a total payment of $67 million. The settlement amount will be paid out in installments over three fiscal years which the Company expects to fund through revenues.

Dominion Voting Systems originally filed its lawsuit against Newsmax in 2021, seeking $1.6 billion in damages. Dominion alleged that certain statements made in Newsmax’s coverage of the 2020 presidential election were defamatory.

From the outset, Newsmax has always maintained that its reporting was not defamatory and that its coverage was consistent with accepted journalistic standards.

“Newsmax believed it was critically important for the American people to hear both sides of the election disputes that arose in 2020,” the Company said in its statement. “We stand by our coverage as fair, balanced, and conducted within professional standards of journalism.”

Despite its confidence in its reporting, Newsmax determined that the Delaware Court with Judge Eric Davis presiding over the case would not provide a fair trial wherein the Company could present standard libel defenses to a jury.

Judge Davis also presided over the case of Dominion vs. Fox News where he was harshly criticized by then Fox’s chief legal officer for his actions and rulings.

“From the very beginning, Judge Davis ruled in ways that strongly favored the plaintiffs and limited Newsmax’s ability to defend itself,” Newsmax stated.

Among the examples Newsmax cited:

• Presumption of guilt: Davis ruled early that Newsmax had committed defamation per se against the plaintiff in each of the 19 alleged statements – depriving the Company of any ability to present a full defense to the serious claims made before a jury which ordinarily decides upon such matters.

• Suppression of critical context: The court indicated that it likely would refuse to allow the jury to hear that Fox News had already paid Dominion $787 million in a settlement-information Newsmax considered essential for the jury to evaluate damages and for them to understand the plaintiff was more than compensated for any potential harm it had alleged.

• Procedural irregularities: Dominion initially sued Newsmax’s parent company rather than its broadcasting subsidiary, Newsmax Broadcasting LLC. Instead of dismissing the suit, Judge Davis simply added the subsidiary and then, without notice or due process to Newsmax Broadcasting, he entered partial summary judgment against the subsidiary – even before it was served with a complaint in the lawsuit.

• Excessive and intrusive discovery: Dominion was permitted to comb through extensive communications including personal emails, cell text messages, and other documents of reporters and company executives that were completely unrelated to the issues in the case.

The pattern of judicial rulings that consistently denied Newsmax due process left the Company to believe it would not receive a fair trial. Faced with these rulings and other constraints, Newsmax chose to settle the case.

“The Delaware Court under Judge Davis effectively enforced a confiscation of our property because our reporting was not always sympathetic to Joe Biden,” Newsmax CEO Christopher Ruddy said.

“The actions taken against Newsmax, and earlier against Fox News, represent a direct attack on free speech and a free press,” he continued.

Newsmax believes Judge Davis’ rulings and actions in Delaware not only threaten the Company’s own rights but also broader constitutional freedoms that will impact many other companies and individuals in the future.

“The judiciary’s willingness to punish news organizations for reporting on matters of urgent national debate undermines the role of the press in a free society,” the Company declared.

Newsmax likely could not have been sued in Delaware had it not been incorporated there at the time Dominion Voting Systems filed its lawsuit. Newsmax encourages every business incorporated in Delaware to reconsider and exit the state, as it did so to Florida. Businesses should re-domicile in jurisdictions that still believe in the rule of law and remain committed to protecting constitutional freedoms for all Americans.

While strongly disagreeing with the Delaware proceedings, Newsmax emphasized that the settlement allows the Company to move forward with clarity and renewed focus. The Company expects to pay the settlement from revenues over three fiscal years and anticipates no disruption to its operations or its growth strategy.

“With these matters resolved, Newsmax is positioned to continue its mission: delivering accurate reporting, fostering vigorous debate, and ensuring Americans have access to diverse viewpoints,” the Company said.

“At a time when public trust in media is at historic lows, our commitment to balanced reporting, coverage of critical issues facing Americans and open dialogue has never been more important.”

About Newsmax

Newsmax Inc. is listed on the NYSE (NMAX) and operates, through Newsmax Broadcasting LLC, one of the nation’s leading news outlets, the Newsmax channel. The fourth highest-rated network is carried on all major pay TV providers. Newsmax’s media properties reach more than 40 million Americans regularly through Newsmax TV, the Newsmax App, its popular website Newsmax.com, and publications such as Newsmax Magazine. Through its social media accounts, Newsmax reaches 20 million combined followers. Reuters Institute says Newsmax is one of the top U.S. news brands and Forbes has called Newsmax “a news powerhouse.”

For more information, please visit Investor Relations | Newsmax Inc.

Forward-Looking Statements

This communication contains forward-looking statements. From time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Forward-looking statements can be identified by those that are not historical in nature. The forward-looking statements discussed in this communication and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. Newsmax does not guarantee future results, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. Forward-looking statements should not be relied upon as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this communication to conform our prior statements to actual results or revised expectations, and we do not intend to do so. Factors that may cause actual results to differ materially from current expectations include various factors, including but not limited to the factors set forth in the sections entitled “Risk Factors” in Newsmax’s Annual Report on Form 10-K for the twelve months ended December 31, 2024, Newsmax’s Quarterly Report on Form 10-Q for the three months ended March 31, 2025, and other filings Newsmax makes with the Securities and Exchange Commission. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. Undue reliance should not be placed on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein.

Investor Contacts

Newsmax Investor Relations
ir@newsmax.com

SOURCE: Newsmax Inc.

View the original press release on ACCESS Newswire

Powered by OpenAI’s Reinforcement Fine-Tuning technology, this first-in-class AI copilot delivers real-time, patient-specific, evidence-based insights, directly within the EHR, underpinned by trusted medical content from BMJ Best Practice

SAN FRANCISCO, CA / ACCESS Newswire / August 18, 2025 / Ambience Healthcare has unveiled Chart Chat, a first-of-its-kind AI copilot designed to integrate directly within Epic’s electronic health record (EHR) system to give healthcare providers context-aware clinical insights. Chart Chat combines patient chart data with medical content from BMJ Best Practice and OpenAI’s Reinforcement Fine Tuning (RFT) technology to create a novel intelligence layer over the EHR.

“This technology can fundamentally change how physicians interact with the medical record,” said Trevor Satterfield, MD, ACMIO, St. Luke’s Health System. “It lets me ask specific questions about the patient’s history or treatment, questions that could take minutes of searching to answer, and get clear, accurate responses in seconds.”

Designed to combat the growing problem of information overload, Chart Chat enables healthcare providers to ask natural language questions about a patient’s history, lab results, prior treatments, and risk factors, and receive relevant, structured answers in seconds. While health systems have experimented with creating their own in-house AI assistants for the EHR, Ambience is the first to launch a production-quality solution.

Unlocking a New Class of Context-Aware Clinical Assistance

What sets Chart Chat apart is that Ambience combines real-time notes from the patient visit with data from the patient’s full medical record. This gives Chart Chat a clear picture of both the current encounter and past history, enabling healthcare providers to get faster, more accurate answers without switching between tools or piecing things together manually.

Key Features for Chart Chat include:

• Chart-Aware Question Answering: Helps doctors quickly find and synthesize key information in a patient’s record, such as identifying medications that didn’t work, making comparisons between past scans, or understanding complex care timelines

• Automated Risk Score Calculation: Uses validated third-party calculators to determine health risk scores, including CHA₂DS₂-VASc, Wells, and HEART, based on the patient’s data

• Clinical Decision Support in Context: Access to BMJ Best Practice’s trusted, evidence-based diagnostic and treatment content (currently in beta) to ensure decisions are informed by the most current and accurate clinical information.

• Integrated Literature Access: Provides quick summaries and references from the latest literature licensed through journal partners, as well as open-source data from PubMed and FDA databases

“Over the past several years, we’ve built and deployed clinical AI that’s trusted by thousands of physicians to support real-time documentation, coding, and patient care,” said Nikhil Buduma, Co-Founder and Chief Scientist at Ambience Healthcare. “Chart Chat builds on that foundation, bringing together cutting-edge language models, real-time EHR context, and trusted clinical content to create the most advanced bedside assistant in healthcare. The launch of Chart Chat marks a pivotal moment for conversational chart intelligence in the United States.”

Chart Chat is rolling out to Ambience users over the next several months. More info can be found on the Ambience website.

About Ambience Healthcare
Ambience Healthcare is the leading AI platform for documentation, coding, and clinical workflow, built to reduce administrative burden and protect revenue integrity at the point of care. Trusted by top health systems across North America, Ambience’s platform is live across outpatient, emergency, and inpatient settings, supporting more than 100 specialties with real-time, coding-aware documentation. The platform integrates directly with Epic, Oracle Cerner, athenahealth, and other major EHRs. Founded in 2020 by Mike Ng and Nikhil Buduma, Ambience is headquartered in San Francisco and backed by Oak HC/FT, Andreessen Horowitz (a16z), OpenAI Startup Fund, Kleiner Perkins, and other leading investors.

Media Contact

Ambience Healthcare
Karina Stabile
Aria Marketing for Ambience Healthcare
kstabile@ariamarketing.com
516.317.5835

SOURCE: Ambience

View the original press release on ACCESS Newswire

NEW YORK CITY, NEW YORK / ACCESS Newswire / August 18, 2025 / Synergy CHC Corp. (NASDAQ:SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced a landmark retail expansion for its FOCUSfactor® Focus + Energy beverage line through EG America, the sixth largest convenience store chain in the United States.

Beginning Q4 2025, FOCUSfactor Focus + Energy will be available nationwide in 1,600+ EG America convenience stores, spanning banners such as Cumberland Farms, Certified Oil, Kwik Shop, Loaf ‘N Jug, Minit Mart, Tom Thumb, and Turkey Hill. This rollout represents one of the Company’s most significant distribution wins to date, positioning FOCUSfactor to capture meaningful share in the booming functional beverage category.

Strategic Growth in Functional Beverages

“EG America has long been recognized as an innovator in convenience retail, and this partnership is a strong validation of our brand strategy,” said Jack Ross, CEO of Synergy CHC Corp. “FOCUSfactor® Focus + Energy was built for today’s performance-driven consumers who demand products that deliver both mental clarity and physical energy. Through EG America’s unmatched reach, we can now bring that benefit to millions of new shoppers nationwide.”

Riding Two Surging Consumer Trends

The EG America partnership places FOCUSfactor at the intersection of two powerful growth drivers:

• Brain Health – A mainstream wellness trend fueled by heightened demand for improved focus, memory, and cognitive support.

• Functional Beverages – Among the fastest-growing segments in the beverage industry, delivering benefits that go beyond taste and refreshment.

With a 25-year legacy in brain health, FOCUSfactor is uniquely positioned to lead the functional beverage space, supported by strong brand recognition and established trust among consumers.

Supporting Expansion with Media & Awareness

“As our client Synergy CHC celebrates this national rollout, New to The Street is proud to align media support with this expansion,” said Vince Caruso, Co-Founder and CEO of New to The Street. “Our TV commercials are rolling out across Bloomberg , Fox Business,and CNBC and will directly support this major expansion, helping to drive awareness, trial, and long-term brand growth for FOCUSfactor®.”

About Synergy CHC Corp.

Synergy CHC Corp. (NASDAQ:SNYR) develops and markets innovative consumer health and wellness products. Its flagship brands include:

• FOCUSfactor® – A clinically studied brain health supplement and functional beverage line with distribution across Costco, Walmart, Amazon, BJ’s, and Walgreens in the U.S., Canada, and U.K.

• Flat Tummy® – A women’s lifestyle and wellness brand focused on confidence, nutrition, and weight management.

With strong retail relationships and a growing portfolio, Synergy is committed to delivering products that empower consumers to live healthier, more energized lives.

About New to The Street

Since 2009, New to The Street has been a trusted name in business television, producing and broadcasting in-depth interviews that spotlight innovative public and private companies. Broadcasting nationwide on Bloomberg and Fox Business as sponsored programming, the platform reaches over 240M U.S. homes weekly and a global digital audience of more than 3.2M YouTube subscribers. With its mix of sponsored TV interviews, earned media placements, and iconic outdoor billboards, New to The Street has become one of the fastest-growing financial media brands in the world.

Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com

Media Contact – New to The Street
Monica Brennan
Monica@NewtoTheStreet.com

SOURCE: New To The Street

View the original press release on ACCESS Newswire

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, reports that its broad-spectrum antiviral drug NV-387 could help reduce resurgence of metastatic cancer caused by awakening of “sleeping” cancer cells due to viral infections. NV-387 has successfully completed a Phase I clinical trial and is being advanced into Phase II clinical trials.

Recently, increase in inflammation, and particularly the cytokine IL-6, caused by viral infections has been found to be linked to an increased risk of resurgence of metastatic cancer, in a study of COVID-19 (SARS-CoV-2 infection) and breast cancer, as well as Influenza virus infections and cancer [1] . This study has further substantiated that viral infections can lead to resurgence of metastatic cancers by re-activating “sleeping” cancer cells.

“NV-387 is a remarkable antiviral drug, in that it not only attacks the virus, but also reduces inflammation, calming the human immune system so that untoward effects do not take place,” said Anil R. Diwan, Ph.D., President and Chairman of the Company, adding, “We have found that NV-387 treatment reduces inflammation markers, particularly, IL-6, thereby protecting lungs. This reduction in inflammation and cyto-protective effect of NV-387 would also help minimize the risk of reawakening cancer, based on these reported studies.”

Thus NV-387 treatment could have a strong impact in the treatment of cancer patients in remission who suffer from a viral infection that could lead to the cancer returning with metastasis to multiple sites in the body.

COVID-19 has become endemic globally, with generally two waves every year. The summer surge is already occurring in the USA, with approximately 4,000 hospitalizations per week in the week ending July 26 at the beginning of the surge, fueled by ever-changing variants [2] . Influenza virus is a well-known endemic virus that causes pandemics globally. RSV is an endemic virus that causes particularly severe diseases in infants and children as well as adults. Measles virus causes “immune system amnesia” and is increasing globally.

NV-387 is the only antiviral drug that has been uniquely found to be effective in the treatment of lethal lung viral infections caused by all of these viruses in animal model studies that are predictive of human clinical effectiveness.

This clearly demonstrates the unmet medical need for NV-387, a broad-spectrum antiviral that the viruses cannot escape even as new variants are created. In contrast, antibodies and vaccines readily fail with new variants arising, as is now well known.

NV-387 treatment has been found to reduce the level of IL-6 in lethal viral infections causing lung diseases in animal models. Excellent protection of lungs was found to occur in NV-387-treated animals but not in ribavirin treated animals in a lethal RSV infection study. Strong protection of lungs was found to occur in NV-387-treated animals in a lethal lung-infection of Influenza A/H3N2 study.

In this Influenza study, the approved drugs Tamiflu (oseltamivir), Rapivab (peramivib), and Xofluza (baloxavir) failed to protect the lungs of animals to any appreciable extent, indicating the superiority and clinical viability of NV-387.

The Company further investigated the extra-ordinary effect of NV-387 on protection of lungs in lethal viral infections. Reduction in inflammatory cytokines, particularly IL-6, was found to occur to an appreciable extent in NV-387 treated animals.

ABOUT NANOVIRICIDES

NanoViricides, Inc. (the “Company”) (www.nanoviricides.com) is a publicly traded (NYSE-American, stock symbol NNVC) clinical stage company that is creating special purpose nanomaterials for antiviral therapy. The Company’s novel nanoviricide™ class of drug candidates and the nanoviricide™ technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The Company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments.

The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The Company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. The Company is currently focused on advancing NV-387 into Phase II human clinical trials.

The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides’ platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company’s pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product.

This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.

The phrases “safety”, “effectiveness” and equivalent phrases as used in this press release refer to research findings including clinical trials as the customary research usage and do not indicate evaluation of safety or effectiveness by the US FDA.

FDA refers to US Food and Drug Administration. IND application refers to “Investigational New Drug” application. cGMP refers to current Good Manufacturing Practices. CMC refers to “Chemistry, Manufacture, and Controls”. CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency’s (EMA) committee responsible for human medicines. API stands for “Active Pharmaceutical Ingredient”. WHO is the World Health Organization. R&D refers to Research and Development.

Contact:
NanoViricides, Inc.
info@nanoviricides.com

Public Relations Contact:
ir@nanoviricides.com

---

[1] https://news.cuanschutz.edu/cancer-center/covid-19-awaken-dormant-cancer-cells . Publication: “Respiratory viral infections awaken metastatic breast cancer cells in lungs”, Chia et al, J DeGregori group, https://doi.org/10.1038/s41586-025-09332-0.

[2] Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2025, August 18. https://covid.cdc.gov/covid-data-tracker.

SOURCE: NanoViricides, Inc.

View the original press release on ACCESS Newswire

Tax experts warn that both casual bettors and high rollers could face unexpected tax bills under increased IRS scrutiny in 2025.

IRVINE, CALIFORNIA / ACCESS Newswire / August 18, 2025 / The Internal Revenue Service is stepping up enforcement on gambling-related income, including online sports betting, casino jackpots, and fantasy sports winnings. Industry experts say many Americans are unaware that even small gambling wins – whether from a Las Vegas slot machine or a mobile betting app – must be reported to the IRS, regardless of whether the casino or platform issues a tax form.

“People tend to think that if they don’t get a W-2G from a casino or a 1099 from an online betting site, they don’t have to report the income,” said a spokesperson for Clear Start Tax, a nationwide tax resolution and relief firm. “That’s simply not true. All gambling winnings are taxable, and failing to report them can lead to penalties, interest, or even an audit.”

The IRS requires taxpayers to report gambling income from all sources, including raffles, lotteries, poker tournaments, horse racing, and sports betting apps. Losses can be deducted, but only up to the amount of winnings – and only if properly documented.

Clear Start Tax warns that the rapid growth of online betting platforms has made it easier for the IRS to track wagers and payouts.

“Betting apps keep detailed transaction records, and those can be obtained by the IRS during an audit,” the spokesperson added. “The days of assuming gambling income will fly under the radar are over.”

To avoid costly mistakes, Clear Start Tax advises winners to:

• Keep detailed records of all bets, wins, and losses.

• Save receipts, tickets, and account statements from betting platforms.

• Report winnings accurately on their tax return, even without an official tax form.

• Consult a tax professional if winnings are substantial or occur in multiple states.

“Winning can be exciting, but ignoring the tax side of it can turn a lucky streak into a financial headache,” the spokesperson said. “The best time to address gambling taxes is before the IRS contacts you – not after.”

By answering a few simple questions, taxpayers can find out if they’re eligible for the IRS Fresh Start Program and take the first step toward resolving their tax debt.

About Clear Start Tax
Clear Start Tax is a national tax resolution and relief firm dedicated to helping individuals and businesses address IRS and state tax issues. With a team of experienced professionals, the company provides strategies for resolving back taxes, negotiating settlements, and achieving compliance. For more information, visit www.clearstarttax.com.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/
(888) 710-3533

Contact Information

Clear Start Tax
Corporate Communications Department
tech@clearstarttax.com
(949) 800-4011

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

Advancing Cubic’s 60mm and 81mm LTS-Mortar systems from prototype to rapid fielding of indirect fire capabilities in the live training environment

SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 18, 2025 / Cubic Defense has been awarded a three-year Other Transaction Agreement (OTA) contract to support U.S. Army PEO STRI programs. The contract provides engineering and manufacturing of 60mm and 81mm mortar Tactical Engagement Simulation Systems (TESS) training systems under the STE Increment 1 rapid fielding to the U.S. Army’s Continental United States (CONUS)-based combat training centers, the National Training Center (NTC) and Joint Readiness Training Center (JRTC).

“Cubic’s LTS-Mortar system is a great example of a training capability originating from our United Kingdom team and refined under the STE LTS Indirect Fire OTA, rapidly progressing to an initial production level that will have a direct impact on training readiness,” commented Alicia Combs, Cubic’s Ground Training Vice President and General Manager. “Mortar teams will finally be able to employ mortar systems in a manner consistent with live fire Tactics, Techniques and Procedures (TTP), while delivering realistic battlefield effects downrange to the Force-on-Force (FoF) training environment, creating a more realistic and immersive training environment.”

Photo courtesy PEO STRI, U.S. Army. 60mm and 81mm Mortar Training System. Cubic’s STE-LTS Mortar systems provide realistic replication of indirect fire weapon systems and their effects.

The LTS-Mortar system began as a prototype under the U.S. Army’s STE LTS FoF Focus Area 2 (Indirect Fires) OTA awarded in 2021. The system was advanced through multiple engineering integration events, Soldier Touch Points (STPs), and with iterative subject matter expert reviews and feedback sessions. The solution provides commanders, battle staff, mortar sections, and supported training units the ability to conduct real-time execution of fire missions, closing a training gap, bringing to bear the effects of indirect fires systems in training and Unified Land Operations.

To learn more about Cubic products and services, visit www.cubic.com.

About Cubic
Cubic creates and delivers technology solutions in transportation that make people’s lives easier by simplifying their daily journeys, and defense capabilities that help promote mission success and safety for those who serve their nation. Led by our talented teams around the world, Cubic is driven to solve global challenges through innovation and service to our customers and partners.

Part of Cubic’s portfolio of businesses, Cubic Defense provides networked Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance and Reconnaissance (C5ISR) solutions and is a leading provider of live, virtual, constructive, and game-based training solutions for both U.S. and Allied Forces. These mission-inspired capabilities enable assured multi-domain access; converged digital intelligence; and superior readiness for defense, intelligence, security, and commercial missions. For more information, visit www.cubic.com.

Media Contact:
Geri MacDonald
Cubic Defense
geri.macdonald@cubic.com

Touchdown PR for Cubic Defense:
Cubicdefense@touchdownpr.com

SOURCE: Cubic Defense

View the original press release on ACCESS Newswire